If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
5th Oct 201612:49 pmRNSNet Asset Value(s)
4th Oct 20165:00 pmRNSConfirmation of Cash Exit Payment and Subscription
30th Sep 20166:30 pmRNSTotal Voting Rights
30th Sep 20166:01 pmRNSCash Received Update
27th Sep 20164:00 pmRNSExpected Receipt of Redemption Proceeds
27th Sep 201611:13 amRNSNet Asset Value(s)
26th Sep 201612:52 pmRNSNet Asset Value(s)
26th Sep 20167:00 amRNSPublication of Circular
20th Sep 20163:43 pmRNSNet Asset Value(s)
16th Sep 20166:12 pmRNSTransaction in Own Shares
13th Sep 201612:46 pmRNSNet Asset Value(s)
9th Sep 20165:30 pmRNSTransaction in Own Shares
7th Sep 201610:08 amRNSNet Asset Value(s)
5th Sep 20162:08 pmRNSNet Asset Value(s)
2nd Sep 20165:30 pmRNSTransaction in Own Shares
1st Sep 20162:20 pmRNSTotal Voting Rights
31st Aug 201610:37 amRNSNet Asset Value(s)
30th Aug 20169:31 amRNSCash Received Update
26th Aug 20166:30 pmRNSHalf Yearly Financial Report
26th Aug 20165:56 pmRNSTransaction in Own Shares
25th Aug 201610:49 amRNSNet Asset Value(s)
23rd Aug 201612:50 pmRNSNet Asset Value(s)
18th Aug 20165:33 pmRNSStatement re: Market Abuse Regulation
17th Aug 20164:03 pmRNSHolding(s) in Company
16th Aug 20164:02 pmRNSNet Asset Value(s)
9th Aug 20164:31 pmRNSConfirmation of Cash Exit Payment and Subscription
9th Aug 20161:25 pmRNSNet Asset Value(s)
4th Aug 20167:00 amRNSNet Asset Value(s)
2nd Aug 20162:39 pmRNSNet Asset Value(s)
28th Jul 201610:00 amRNSNet Asset Value(s)
21st Jul 201611:35 amRNSNet Asset Value(s)
20th Jul 20166:30 pmRNSResult of AGM
15th Jul 20165:18 pmRNSNet Asset Value(s)
14th Jul 20166:00 pmRNSNet Asset Value(s)
14th Jul 20163:49 pmRNSUpdate re Return of Capital
13th Jul 20164:29 pmRNSNotice of AGM
13th Jul 20163:56 pmRNSNet Asset Value(s)
12th Jul 201612:17 pmRNSNet Asset Value(s)
4th Jul 20166:00 pmRNSNet Asset Value(s)
1st Jul 20166:00 pmRNSRedemption Proceeds
30th Jun 201612:48 pmRNSNet Asset Value(s)
23rd Jun 20161:19 pmRNSNet Asset Value(s)
16th Jun 201612:16 pmRNSNet Asset Value(s)
10th Jun 20164:30 pmRNSNet Asset Value(s)
9th Jun 201610:30 amRNSNet Asset Value(s)
6th Jun 20163:45 pmRNSNet Asset Value(s)
3rd Jun 20167:00 amRNSAppointment of Non-Executive Director
3rd Jun 20167:00 amRNSConfirmation of Cash Exit Payment and Subscription
2nd Jun 20161:30 pmRNSNet Asset Value(s)
1st Jun 20166:00 pmRNSReceipt of Redemption Proceeds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.